NCI Small Grants Program for Cancer Research (NCI Omnibus R03)

PAR-14-007
NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Department of Health and Human Services
National Institutes of Healthall-of-us-v-cancer

Section I. Funding Opportunity Description

This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), supports discrete, well-defined projects in any area of cancer research using the NIH R03 small grant mechanism.

The NIH R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in 2 years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following:

  • Pilot or feasibility studies;
  • Secondary analysis of existing data;
  • Small, self-contained research projects;
  • Development of research methodology; and
  • Development of new research technology.
Specific Research Objectives

All areas of cancer research relevant to the mission of the NCI are appropriate for projects submitted in response to this FOA (for a list of extramural research funding programs at the NCI, go to http://www.cancer.gov/researchandfunding/extramural). Projects proposed in response to this FOA may involve basic, translational, clinical, and/or population research related to cancer. Examples of relevant areas include but are not limited to studies of: cancer biology; cancer control; cancer diagnosis; cancer disparities; cancer prevention; and cancer treatment.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-007
Funding Opportunity Title: NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 21, 2013
Last Updated Date: Aug 26, 2016
Original Closing Date for Applications: Jan 05, 2017  
Current Closing Date for Applications: Aug 26, 2016  
Archive Date: Sep 26, 2016
Estimated Total Program Funding:  
Award Ceiling: $50,000
Award Floor:  

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
State governments
Public housing authorities/Indian housing authorities
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), of the National Institutes of Health (NIH) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)

PAR-16-284
Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)
Department of Health and Human Services
National Institutes of Healthcancer-682x1024

Section I. Funding Opportunity Description

The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation’s biomedical, behavioral, and clinical research needs. In addition to this opportunity, NIH Institutes and Centers (ICs) support a variety of other mentored career development programs designed to foster the transition of new investigators to research independence. These other programs may be more suitable for particular candidates.  NIH also supports non-mentored career development programs for independent investigators. More information about Career programs may be found at the NIH Extramural Training Mechanisms website.

The objectives of the NIH Academic Career Award (K07) are to increase the pool of individuals with academic and research expertise in a specific area of biomedical research and to enhance the educational or research capacity at the grantee institution. The K07 Development Award supports more junior investigators who are interested in developing academic and research expertise in a particular health-related field, as a way to increase the overall pool of individuals capable of research or teaching in the identified area. Research, teaching, and leadership skills are to be learned during the tenure of the award. Curriculum building skills are encouraged.

The objective of the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) is to increase the pool of individuals with academic and research expertise in these specific areas of biomedical research. The award provides salary and mentored research support for a sustained period of “protected time” to junior investigators who are interested in developing academic and research expertise in these particular health-related fields. Candidates must have no more than 8 years of research experience after the terminal doctoral degree at the time of the initial or the subsequent resubmission application; clinical training is not included within this 8-year limit. The expectation is that, through this sustained period of research career development and training under the guidance of an experienced mentor in the biomedical, behavioral, or clinical sciences, awardees will launch fully independent research careers and become competitive for new research project grant (e.g., R01) funding.

For the purpose of this funding opportunity, cancer control research is defined as “basic and applied research in the behavioral sciences that independently or in combination with biomedical approaches reduces cancer risk, incidence, morbidity, and mortality across the lifespan and over the entire process of carcinogenesis from primary behavioral prevention in youth, to screening, treatment, and survivorship” (Report of the NCI Cancer Control Progress Review Group, 1997-1998 ).

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-284
Funding Opportunity Title: Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.398 — Cancer Research Manpower
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Posted Date: May 25, 2016
Last Updated Date: May 25, 2016
Original Closing Date for Applications: Jan 07, 2018  
Current Closing Date for Applications: Jan 07, 2018  
Archive Date: Feb 07, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants:
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) is to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-284.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS)

RFA-DP-16-006
Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS)
Department of Health and Human Services
Centers for Disease Control and Prevention

Background and Purpose

The purpose of the Prevention Research Centers (PRC) program’s Special Interest Projects (SIPs) mechanism is to support
supplemental projects in health promotion and disease prevention research. A major focus of this supplemental funding program is
to design, test, and disseminate effective applied public health prevention research strategies.
The US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP) seeks competitive supplement cooperative agreement
applications for the Health Promotion and Disease Prevention Research Centers Program. This FOA aligns with the following
public health priorities:
1. Healthy People 2020 Objectives related to health promotion and disease prevention.
2. The National Prevention Strategy.
3. CDC’s Winnable Battles which cover health topic of reducing tobacco use.
4. The NCCDPHP Domains of (a) strategies to improve community-clinical linkages that support patient efforts to manage their
conditions or disease risk, (b) conduct surveillance to enhance prevention, and reduce premature morbidity and mortality due to
chronic diseases, (c) health systems interventions to improve the effective delivery and use of quality clinical and other
preventative services to prevent disease; detect disease early; reduce or eliminated risk factors; mitigate or manage complications;
and support patient self-management education, (d) defining and supporting evaluation and applied research activities to reduce
disparities in cancer rates among different population groups, (e) health system interventions to improve the effective delivery and
use of clinical and other preventive services, and (f) support environmental approaches that promote health and support and
reinforce healthful behaviors in worksites.

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-16-006
Funding Opportunity Title: Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS)
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 8
CFDA Number(s): 93.135 — Centers for Research and Demonstration for Health Promotion and Disease Prevention
Cost Sharing or Matching Requirement: No
Posted Date: Dec 23, 2015
Creation Date: Dec 23, 2015
Original Closing Date for Applications: Feb 22, 2016  Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Feb 22, 2016   Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Mar 23, 2016
Estimated Total Program Funding: $3,375,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants:
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Competition is limited to Prevention Reseach Centers (PRCs) institutions funded under DP14-001. Special eligibility requirement(s) may apply to each SIP (see Section IX. Special Interest Project Description).

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: This RFA will provide supplemental funding to Prevention Research Centers (PRCs) to design, test, and disseminate effective applied public health prevention research strategies to include behavioral interventions, environmental or system-wide solutions, and strategies that address major causes of disease and disability. Research strategies align with public health priorities such as the Healthy 2020 topic areas: Cancer, Oral Health, and Workplace Health.
Link to Additional Information:
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michael Brown MAB5@cdc.gov
Grants Policy

PRIVATE FOA: Damon Runyon Cancer Research Foundation Invites Applications for Physician-Scientist Training Award [K08 or K23]

Damon Runyon Cancer Research Foundation Invites Applications for Physician-Scientist Training Award

A scientist holding a Petri Dish with Virus and bacteria cells.
SOURCE: Damon Runyon Cancer Research Foundation
APPLICATION DEADLINE: 12/1/15.
$ AVAILABLE: The award will provide up to $460,000 in financial support over four years. In addition, the foundation will retire up to $100,000 of any outstanding medical school debt owed by a grant recipient.
ELIGIBILITY: To be eligible, physician-scientist applicants (MDs only) must have completed their residencies and clinical training, be U.S. specialty board-eligible prior to the award start date, have not had more than three years of postdoctoral laboratory research experience, and be able to devote at least 80 percent of their time and effort to DRCRF-supported research. Awardees may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source or federal government (e.g., K08 or K23) may be held concurrently with this award.
PURPOSE: The Damon Runyon Cancer Research Foundation is accepting applications for its 2016 Physician-Scientist Award.
The annual program provides physicians who wish to pursue a career in cancer research with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed their clinical training.
The goals of the program are to transform these talented individuals into the highest quality physician-scientists capable of conducting research that has the potential to transform the diagnosis, treatment, and/or prevention of cancer; and to eliminate the financial disincentive to entering this career path.
CONTACT: Award Programs, (212) 455-0520, email: awards@damonrunyon.org. For more information see: http://www.damonrunyon.org/for_scientists/more/physician_scientist_training_award_overview
From The Foundation Center’s Philanthropy News Digest web site, accessed 10/22/15icon
Subject(s) cancer research, health professions training

Genomic Data Analysis Network: Visualization Genomic Data Center (U24)

RFA-CA-15-019h
Genomic Data Analysis Network: Visualization Genomic Data Center (U24)
Department of Health and Human Services
National Institutes of Health

Research Objectives and Main Requirements for This FOA

Expectations for GDACs in the Genomic Data Analysis Network. As a whole the GDACs must be able to:

  • Implement bioinformatic  pipelines using existing state-of-the-art tools for timely high-throughput processing and integrated analyses of genome-wide data;
  • Develop and implement new bioinformatic and computational tools to capture key biological parameters such as pathway analysis, data integration with visualization, and integrated cancer biology;
  • Develop pipeline and network-wide quality control methods for the system developed as a response to the goals stated above; and
  • Process/integrate analytical data from other components of the network to generate disease level findings and interpretations as well as cross-disease analyses.
  • These goals will necessitate continuous communication and interactions among the members of the network.  Each member of the GDAC group will have distinct functions and capabilities and be responsible for individual analytical components.

Interactions of GDACs with other members of the network. All GDAC awardees, including the Visualization GDAC to be supported under this FOA, must be able to accommodate their activities in the general scheme of the coordinated interactions across the various resources as outlined below.

  • Biospecimen Core Resource (BCR): The BCR serves as the tissue processing center and provides the molecular biomolecules for all CCG-approved projects. Standard operating procedures are used for clinical data collection, sample collection, pathological examination, biomolecule (e.g., DNA and RNA) extractions, quality control, laboratory data collection, and biomolecule distribution to the Cancer Genome Characterization Centers. The samples are required to have patient informed consent for the public release of data or an IRB waiver.
  • Genome Characterization Centers (GCCs): GCCs conduct high-throughput comprehensive genome-wide analyses using validated technologies (e.g., gene expression profiling, detection of chromosomal segment copy numbers alteration) to reveal the spectrum of genomic changes that exist in human tumors and to identify genomic regions for further characterization. The data generated by the characterization centers will be the main (but not only) starting point for the analyses performed by the GDACs.
  • Genomic Data Analysis Network (GDAN): The aggregated capabilities of the awardees from the present FOA and its companions (RFA-CA-15-018 and RFA-CA-15-020) will produce the bulk of the analysis required to interpret the data generated by the GCCs described above. This group will work closely and collaboratively with all other components of the pipeline and be responsive to the necessities of the analysis requests posed by the AWGs that will be formed for each CCG-approved project.
  • Data Management, Storage and Public Access:  The whole of the data generated by CCG-approved projects is presented to the scientific community though publically-available databases that contain not only the raw data and associated metadata, but all of the analysis files generated in the course of each project. At the time of this FOA, that task is performed by the DCC (through project-specific data portals) and CGHub. In the near future, these activities will be consolidated under a single entity, the GDC, where all members of the network will deposit their data.

Required Team Expertise. Each GDAC applicant team must have current expertise in computational data analysis and genomics-specific bioinformatics as well as clinical oncology and/or cancer biology. GDACs would benefit greatly by being jointly led by two investigators: (i) an expert in bioinformatics/computation and (ii) either a clinical oncologist or a cancer biologist who can help to guide the analyses and contribute to the interpretation of the results at the disease-level.

GDACs differ by the proportion of the effort devoted to the development of novel analyses, but each GDAC will be required to develop novel approaches to data analysis and data integration.  The analytical pipelines will be available as a resource to the scientific community for data integration and for advanced translational evaluation of genomic data.  The analytical pipelines may result in valid conclusions which are not 100% concordant due to the different analytical methods used.  The GDACs will need to develop annotation which will be made available along with the pipeline to explain any differences in data interpretation to the research community.

Specific Objectives for Visualization GDAC. The proposed Visualization GDAC must have all the expertise, personnel, instrumentation and throughput capabilities that will be required for the objectives defined below (with additional specific details in Section IV, under “Research Strategy”.)

  • Objective 1: Development of innovative bioinformatics and computational tools and methodologies (requires drawing clinical and biological correlations).
  • Objective 2: Conducting integrative analysis of data sets generated by GCCs using the bioinformatics tools developed by each GDAC.

Objective 3: Implementing an integrative bioinformatics approach utilizing existing bioinformatic tools for timely high-throughput processing and analyses of genome-wide data.

  • Data Sharing Requirements for GDACs:

Public availability of data/information generated by all genomics data resulting from NCI-supported initiatives will be critical to facilitate disease-relevant discoveries of clinical significance and a goal of this initiative. Therefore, sharing as a public resource all rigorously validated data resulting from GDACs is essential for this initiative. For details, see Section IV.2, under “Resource Sharing Plan”.

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-15-019
Funding Opportunity Title: Genomic Data Analysis Network: Visualization Genomic Data Center (U24)
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
Cost Sharing or Matching Requirement: No
Posted Date: Oct 22, 2015
Creation Date: Oct 22, 2015
Original Closing Date for Applications: Jan 27, 2016  
Current Closing Date for Applications: Jan 27, 2016  
Archive Date: Feb 27, 2016
Estimated Total Program Funding:
Award Ceiling: $660,000
Award Floor:

Eligibility

Eligible Applicants:
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Private institutions of higher education
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Independent school districts
Special district governments
Native American tribal governments (Federally recognized)
City or township governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) is a part of cancer genomics programs supported by the National Cancer Institute (NCI) and managed by its Center for Cancer Genomics (CCG). The overall goal of all CCG programs is to help elucidate the mechanisms of cancer initiation and evolution, as well as resistance to therapy by means of genomic characterization of well-annotated, high quality tumor samples. The acquired knowledge could facilitate and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-019.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)

NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)  Department of Health and Human Services  National Institutes of Health

Purposesupport_cancer_research

The purpose of this funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), is to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research in all areas relevant to the mission of the NCI. By using the R21 mechanism, this FOA will support exploratory/developmental projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, and/or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).

Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. Conversely, long-term projects, or projects designed to increase knowledge in a well-established area, should not be submitted as R21 applications.

Applications submitted under this mechanism should break new ground or extend previous discoveries toward new directions or applications. Projects of limited cost or scope that use widely accepted approaches and methods within well-established fields are better suited for the R03 small grant mechanism, which is presently also supported by the NCI Omnibus R03 FOA,PAR-14-007.

Specific Research Objectivescancer research ad2_0

All areas of cancer research relevant to the mission of the NCI are appropriate for projects submitted to this FOA (for a list of extramural research funding programs at the NCI, go tohttp://www.cancer.gov/researchandfunding/extramural). Proposed projects may involve basic, translational, clinical, and/or population research. Examples of relevant areas include but are not limited to studies of: cancer biology; cancer control; cancer diagnosis; cancer disparities; cancer prevention; and cancer treatment.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-15-340
Funding Opportunity Title: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Posted Date: Sep 1, 2015
Creation Date: Sep 1, 2015
Original Closing Date for Applications: Nov 10, 2015  
Current Closing Date for Applications: Nov 10, 2015  
Archive Date: Dec 11, 2015
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

ligibility

Eligible Applicants:
City or township governments
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
For profit organizations other than small businesses
Private institutions of higher education
County governments
Native American tribal governments (Federally recognized)
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-15-340.html